Hope in Focus, a nonprofit organization dedicated to advancing treatments and support for Leber congenital amaurosis (LCA), will host its annual fundraiser, Dinner in the Dark, on Saturday, [...]
We’re in the process of relaunching the Hope in Focus website, and we need the help of a professional writer/editor to support this project. Some sections of the web copy […]
Ledyard, CT — [6/30/2024] — Hope in Focus, a nonprofit organization dedicated to supporting individuals and families affected by Leber congenital amaurosis (LCA) and other rare inherited retinal [...]
Ledyard, Connecticut (6/4/2025)—Hope in Focus, a nonprofit dedicated to advancing treatments and cures for blindness caused by the rare inherited retinal disease Leber congenital amaurosis (LCA), [...]
Nothing is more hopeful or gratifying for the retinal disease community than an emerging or FDA-approved therapy that provides vision to people with advanced retinal disease. Such is the case [...]
We are pleased to announce that the 2025 LCA Family Conference will be hosted at the Embassy Suites in Minneapolis, Minnesota, from Friday, June 20 to Saturday, June 21, 2025. […]
Hope in Focus will host its signature fundraising event of the year – Dinner in the Dark – on Saturday, Nov. 2, 2024, at Foxwoods Resort Casino in Mashantucket, CT. […]
In December 2023, ProQR sold its sepofarsen (LCA10) and ultevursen (USH2A) programs to Théa, a large European biotechnology company focused on ophthalmology. Théa, through its new dedicated [...]
We are pleased to announce that Hope in Focus has been awarded a $5,000 grant on September 3, 2024, from Amgen through their #RAREis Global Advocate Grant prog ram. This […]
Hope in Focus Director of Outreach and Development Courtney Coates attended the ARVO Annual Meeting on behalf of the organization to learn more about current LCA research to raise awareness […]
